Clinical Trial Update: PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic/pharmacodynamic study comparing two agalsidase formulations given as a single 1 mg/kg intravenous dose in healthy volunteers; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• agalsidase alfa (agalsidase alfa)
• agalsidase beta (agalsidase beta)

Snippet

Sponsor: Bio Sidus SA | Conditions: Fabry Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-03-15